Abstract The ovary plays a central role in female reproductive and endocrine health, yet ovarian biology remains structurally fragmented across disciplines including reproductive medicine, endocrinology, toxicology, and bioengineering. This fragmentation limits the integration of mechanistic insights, slows clinical translation, and constrains our understanding of the ovary as a complex, multi-scale organ. Recent advances in technologies such as single-cell analysis, organoid systems, and biomaterials have generated unprecedented knowledge, but these developments often remain siloed. Here, we argue that advancing the field requires the establishment of dedicated integrative platforms that bridge basic, translational, and clinical research. Using recent interdisciplinary initiatives as a proof-of-concept, we propose key principles for such platforms and call for structural changes in how ovarian research is organized, supported, and disseminated.
Amorim et al. (Mon,) studied this question.